These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15856298)

  • 1. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
    Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
    Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
    Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
    Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
    Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
    Yeh JJ; Hsu NY; Hsu WH; Tsai CH; Lin CC; Liang JA
    Lung; 2005; 183(3):177-83. PubMed ID: 16078039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
    Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
    Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
    Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
    Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
    Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
    Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
    Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
    Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer.
    Han L; Wang YF; Zhang Y; Wang N; Guo XJ; Yang JK; Wang KP; Liu SN; Fan QX; Li K; Jiang JH; Wang QD
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):365-72. PubMed ID: 22782455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
    Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of P-glycoprotein and lung resistance protein in breast carcinoma and its relationship with prognosis].
    Yu P; Xiao NX; Chen YP
    Ai Zheng; 2003 Dec; 22(12):1339-42. PubMed ID: 14693064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].
    Li L; Su LP; Ma L; Zhao J; Zhu L; Zhou YA
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):199-202. PubMed ID: 19615260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
    Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM
    Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
    Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
    Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.
    Harada T; Ogura S; Yamazaki K; Kinoshita I; Itoh T; Isobe H; Yamashiro K; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].
    Peng ZM; Luo J; Wang WB; Wang XH; Chen JH; Lan SM
    Ai Zheng; 2004 Aug; 23(8):963-7. PubMed ID: 15301725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.